ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.

化学 腺苷 药理学 腺苷激酶 核苷 受体 生物化学 腺苷脱氨酶 生物
作者
Michael F. Jarvis,Hongbo Yu,Kathy L. Kohlhaas,Karen M. Alexander,Chih‐Hung Lee,Meiyan Jiang,Shripad S. Bhagwat,Michael E. Williams,Elizabeth A. Kowaluk
出处
期刊:PubMed 卷期号:295 (3): 1156-64 被引量:84
链接
标识
摘要

Adenosine (ADO) is an inhibitory neuromodulator that can increase nociceptive thresholds in response to noxious stimulation. Inhibition of the ADO-metabolizing enzyme adenosine kinase (AK) increases extracellular ADO concentrations at sites of tissue trauma and AK inhibitors may have therapeutic potential as analgesic and anti-inflammatory agents. ABT-702 is a novel and potent (IC(50) = 1. 7 nM) non-nucleoside AK inhibitor that has several orders of magnitude selectivity over other sites of ADO interaction (A(1), A(2A), A(3) receptors, ADO transporter, and ADO deaminase). ABT-702 was 1300- to 7700-fold selective for AK compared with a number of other neurotransmitter and peptide receptors, ion channel proteins, neurotransmitter/nucleoside reuptake sites, and enzymes, including cycloxygenases-1 and -2. ABT-702 was equipotent (IC(50) = 1.5 +/- 0. 3 nM) in inhibiting native human AK (placenta), two human recombinant isoforms (AK(long) and AK(short)), and AK from monkey, dog, rat, and mouse brain. Kinetic studies revealed that AK inhibition by ABT-702 was competitive with respect to ADO and noncompetitive with respect to MgATP(2-). AK inhibition by ABT-702 was demonstrated to be reversible after 4 h of dialysis. ABT-702 is orally active and fully efficacious in reducing acute somatic nociception (ED(50) = 8 micromol/kg i.p.; 65 micromol/kg p.o.) in the mouse hot-plate assay. ABT-702 also dose dependently reduced nociception in the phenyl-p-quinone-induced abdominal constriction assay. The antinociceptive effects of ABT-702 in the hot-plate assay were blocked by the nonselective ADO receptor antagonist theophylline, and by the A(1)-selective antagonist cyclopentyltheophylline (10 mg/kg i.p.), but not by a peripherally selective ADO receptor antagonist 8-(p-sulfophenyl)-theophylline (50 mg/kg i.p.), by the A(2A)-selective antagonist 3, 7-dimethyl-1-propargylxanthine (1 mg/kg i.p.) or the opioid antagonist naloxone (5 mg/kg i.p.). Thus, ABT-702 is a novel and potent non-nucleoside AK inhibitor that effectively reduces acute thermal nociception in the mouse by a nonopioid, non-nonsteroidal anti-inflammatory drug, ADO A(1) receptor-mediated mechanism.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
dd发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
阔达的凡发布了新的文献求助10
1秒前
2秒前
4秒前
lemon完成签到 ,获得积分10
4秒前
aaaaa发布了新的文献求助10
5秒前
虚心稚晴完成签到,获得积分10
6秒前
6秒前
7秒前
aaaaa发布了新的文献求助10
7秒前
aaaaa发布了新的文献求助10
7秒前
aaaaa发布了新的文献求助10
8秒前
bamiaojinyu发布了新的文献求助10
8秒前
阔达的凡完成签到,获得积分10
8秒前
8秒前
aaaaa发布了新的文献求助10
9秒前
lailai发布了新的文献求助10
9秒前
外向向雁完成签到,获得积分10
10秒前
飞鸟发布了新的文献求助10
15秒前
lili完成签到 ,获得积分10
16秒前
CY关闭了CY文献求助
18秒前
20秒前
21秒前
wdx完成签到,获得积分10
22秒前
啊啊发布了新的文献求助10
22秒前
23秒前
RIcky完成签到,获得积分10
23秒前
传奇3应助飞鸟采纳,获得10
25秒前
26秒前
26秒前
自由的厉给自由的厉的求助进行了留言
26秒前
jay555完成签到,获得积分10
27秒前
紫葡萄发布了新的文献求助10
27秒前
简单的笑蓝完成签到 ,获得积分10
29秒前
12345发布了新的文献求助10
31秒前
31秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
【本贴是提醒信息,请勿应助】请在求助之前详细阅读求助说明!!!! 20000
Evolution 4000
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
La Chine révolutionnaire d'aujourd'hui / Van Min, Kang Hsin 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3037433
求助须知:如何正确求助?哪些是违规求助? 2696381
关于积分的说明 7356729
捐赠科研通 2338128
什么是DOI,文献DOI怎么找? 1237687
科研通“疑难数据库(出版商)”最低求助积分说明 602539
版权声明 595038